Literature DB >> 7756602

Expression of cyclo-oxygenase 2 in rat brain following kainate treatment.

J Chen1, T Marsh, J S Zhang, S H Graham.   

Abstract

The transcriptional expression of the mitogen-inducible cyclo-oxygenase (COX-2) was investigated by in situ hybridization of kainate-treated rat brains. Kainate treatment rapidly induced COX-2 mRNA in neurons throughout the forebrain which was blocked by pretreatment with MK-801 or NBQX. Transient expression of COX-2 mRNA lasting about 8 h occurred in areas that were resistant to neuronal necrosis, while COX-2 mRNA expression persisted for 24-72 h in regions that were vulnerable. These results show that seizures result in increased COX-2 expression and support the hypothesis that COX-2 could be an important factor in the pathogenesis of delayed neuronal necrosis due to kainate excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756602

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  12 in total

1.  Cyclooxygenase-2 expression and effect of celecoxib in flurothyl-induced neonatal seizure.

Authors:  Doo Kwun Kim; Tae Jung Jang
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

Review 2.  Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.

Authors:  J Y Jouzeau; B Terlain; A Abid; E Nédélec; P Netter
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

Review 3.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

4.  Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury.

Authors:  Jonas J Gopez; Hongfei Yue; Ram Vasudevan; Amir S Malik; Lester N Fogelsanger; Shawn Lewis; David Panikashvili; Esther Shohami; Susan A Jansen; Raj K Narayan; Kenneth I Strauss
Journal:  Neurosurgery       Date:  2005-03       Impact factor: 4.654

5.  Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat.

Authors:  K I Strauss; M F Barbe; R M Marshall; R Raghupathi; S Mehta; R K Narayan
Journal:  J Neurotrauma       Date:  2000-08       Impact factor: 5.269

6.  Prophylactic, prandial rofecoxib treatment lacks efficacy against acute PTZ-induced seizure generation and kindling acquisition.

Authors:  Robert J Claycomb; Sandra J Hewett; James A Hewett
Journal:  Epilepsia       Date:  2011-01-10       Impact factor: 5.864

7.  Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death.

Authors:  Kenneth I Strauss; Ann M Marini
Journal:  J Neurotrauma       Date:  2002-05       Impact factor: 5.269

Review 8.  Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors:  Kenneth I Strauss
Journal:  Brain Behav Immun       Date:  2007-11-08       Impact factor: 7.217

9.  Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia.

Authors:  M Nakayama; K Uchimura; R L Zhu; T Nagayama; M E Rose; R A Stetler; P C Isakson; J Chen; S H Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites.

Authors:  Hao Liu; Wenjin Li; Marie E Rose; Jordan L Pascoe; Tricia M Miller; Muzamil Ahmad; Samuel M Poloyac; Robert W Hickey; Steven H Graham
Journal:  Neurotoxicology       Date:  2013-08-22       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.